Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

National push to protect tiniest patients from hospital infections

NCT ID NCT07109791

Summary

This study aims to create better national guidelines for preventing and treating ventilator-associated pneumonia (VAP) in very small, premature babies. Researchers will analyze hospital records from 1,500 infants across Canada to understand how often these infections occur, what causes them, and how they're currently treated. The goal is to develop a standardized approach that reduces infections, limits unnecessary antibiotic use, and improves care for vulnerable newborns.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for VENTILATOR-ASSOCIATED PNEUMONIA (VAP), NEONATAL are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Royal Alexandra Hospital

    RECRUITING

    Edmonton, Alberta, T5H 3V9, Canada

    Contact Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.